Monday, July 25, 2016

UPDATE 1-Gilead cuts 2016 sales forecast, cites hepatitis C drugs

July 25 (Reuters) - Gilead Sciences Inc on Monday

lowered its full-year sales outlook, citing slower-than-expected

sales of its key hepatitis C drugs, and said second-quarter

profits fell 22 percent.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)